Showing results (11-20 of 394) with videos related to
Sort By:
Pageof 40
Transplant International : Official Journal of the European Society for Organ Transplantation|May 30, 2020
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced-intensity hematopoietic peripheral blood cell transplant - a retrospective studyNahid Rashid, Michael Slade, Ramzi Abboud, et al.Cell Reports. Medicine|March 4, 2022
Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their dueRoman M Shapiro, Rizwan RomeeCurrent Hematologic Malignancy Reports|November 12, 2020
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and ChallengesJessica S Little, Rizwan RomeeStem Cells Translational Medicine|December 24, 2023
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based ImmunotherapyAndreia Maia, Mubin Tarannum, Rizwan RomeeBest Practice & Research. Clinical Haematology|December 7, 2010
Can every patient be mobilized?John F DiPersioBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid LeukemiaJoan How, Michael Slade, Khoan Vu, et al.Frontiers in Immunology|April 11, 2022
Innovative Strategies to Improve the Clinical Application of NK Cell-Based ImmunotherapyMubin Tarannum, Rizwan Romee, Roman M ShapiroBlood Cancer Discovery|April 17, 2026
CAR-NK Cells in B-cell Lymphoma: A New Frontier toward Accessible and Scalable Cellular TherapyRémy Duléry, Karl-Johan Malmberg, Rizwan RomeeCancer Journal (Sudbury, Mass.)|March 22, 2021
Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future?Alaa Kassim Ali, Mubin Tarannum, Rizwan RomeeSeminars in Hematology|April 20, 2023
The natural killer cell immunotherapy platform: An overview of the landscape of clinical trials in liquid and solid tumorsSara Piccinelli, Rizwan Romee, Roman M ShapiroPageof 40